Newbury Pharmaceuticals AB Logo

Newbury Pharmaceuticals AB

Develops specialty prescription drugs for Scandinavia in oncology, rare diseases & neurology.

NEWBRY | ST

Overview

Corporate Details

ISIN(s):
SE0015244884
LEI:
549300F7XHU3I8CWL373
Country:
Sweden
Address:
Medicon Village, 223 81 Lund
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Newbury Pharmaceuticals AB is a rapidly growing hybrid pharmaceutical company specializing in specialty prescription drugs, innovation, and branded products. The company focuses on the Scandinavian market, building a pipeline of proprietary and licensed products. Its primary therapeutic areas of interest include oncology, rare diseases, and neurology. Newbury Pharmaceuticals positions itself as a local champion and an alternative partner to larger multinational pharmaceutical corporations in the region.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Newbury Pharmaceuticals AB and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2018-10-05 13:14
Regulatory News Service
Edison Investment Research Limited: Edison issues outlook on NeuroVive Pharmace…
English 10.7 KB
2017-06-29 13:30
Report Publication Announcement
EQS-News: Edison Investment Research Limited: Edison issues initiation on Neuro…
English 11.1 KB

Automate Your Workflow. Get a real-time feed of all Newbury Pharmaceuticals AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Newbury Pharmaceuticals AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-04-29 Johan Strömqvist Other Sell 13,564 40,692.00 SEK
2025-04-29 Johan Strömqvist Other Sell 10,400 30,888.00 SEK
2025-04-29 Johan Strömqvist Other Buy 10,200 30,804.00 SEK
2025-04-29 Johan Strömqvist Other Buy 5,000 15,570.50 SEK
2025-04-29 Johan Strömqvist Other Buy 5,000 15,200.00 SEK
2025-04-29 Johan Strömqvist Other Sell 2,436 7,332.36 SEK
2025-04-29 Johan Strömqvist Other Sell 100 305.00 SEK
2024-08-03 Andreas Hedskog Other Buy 200,000 178,000.00 SEK
2024-08-03 Andreas Hedskog Other Other 200,000 N/A
2024-01-22 Alsakali Equity AB Other Buy 4,000 18,920.00 SEK

Peer Companies

Company Country Ticker View
2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden 2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
Abliva Logo
Develops clinical-stage medicines for rare primary mitochondrial diseases to restore cell function.
Sweden ABLI
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
Active Biotech Logo
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
Sweden ACTI
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden ACUC

Talk to a Data Expert

Have a question? We'll get back to you promptly.